Silo Pharma Inc
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's … Read more
Market Cap & Net Worth: Silo Pharma Inc (SILO)
Silo Pharma Inc (OTCQB:SILO) has a market capitalization of $14.38 Million ($14.38 Million) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #32187 globally and #10568 in its home market, demonstrating a -20.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Silo Pharma Inc's stock price $1.08 by its total outstanding shares 13318273 (13.32 Million).
Silo Pharma Inc Market Cap History: 2015 to 2025
Silo Pharma Inc's market capitalization history from 2015 to 2025. Data shows change from $14.65 Million to $14.38 Million (-4.62% CAGR).
Index Memberships
Silo Pharma Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.00% | #823 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #2612 of 3165 |
Weight: Silo Pharma Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Silo Pharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Silo Pharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
184.71x
Silo Pharma Inc's market cap is 184.71 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $14.65 Million | $-145.19K | -$409.50K | -100.91x | N/A |
| 2016 | $3.33 Million | $-669.48K | -$1.11 Million | -4.97x | N/A |
| 2017 | $2.66 Million | $847.41K | $356.54K | 3.14x | 7.47x |
| 2019 | $4.66 Million | $40.57K | -$1.05 Million | 114.90x | N/A |
| 2020 | $5.65 Million | $40.92K | -$3.13 Million | 138.12x | N/A |
| 2021 | $95.23 Million | $71.26K | $3.90 Million | 1336.24x | 24.39x |
| 2022 | $44.75 Million | $72.10K | -$3.91 Million | 620.64x | N/A |
| 2023 | $19.18 Million | $72.10K | -$3.70 Million | 265.99x | N/A |
| 2024 | $13.32 Million | $72.10K | -$4.39 Million | 184.71x | N/A |
Competitor Companies of SILO by Market Capitalization
Companies near Silo Pharma Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Silo Pharma Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Silo Pharma Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Silo Pharma Inc's market cap moved from $14.65 Million to $ 14.38 Million, with a yearly change of -4.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $14.38 Million | +8.00% |
| 2024 | $13.32 Million | -30.56% |
| 2023 | $19.18 Million | -57.14% |
| 2022 | $44.75 Million | -53.01% |
| 2021 | $95.23 Million | +1584.73% |
| 2020 | $5.65 Million | +21.26% |
| 2019 | $4.66 Million | -65.00% |
| 2018 | $13.32 Million | +400.00% |
| 2017 | $2.66 Million | -20.00% |
| 2016 | $3.33 Million | -77.27% |
| 2015 | $14.65 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Silo Pharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.38 Million USD |
| MoneyControl | $14.38 Million USD |
| MarketWatch | $14.38 Million USD |
| marketcap.company | $14.38 Million USD |
| Reuters | $14.38 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.